These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23757311)

  • 21. Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo.
    Gao J; Chen T; Zhao D; Zheng J; Liu Z
    PLoS One; 2016; 11(12):e0168219. PubMed ID: 27973574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy.
    Fajardo G; Zhao M; Powers J; Bernstein D
    J Mol Cell Cardiol; 2006 Mar; 40(3):375-83. PubMed ID: 16458323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
    Cote B; Carlson LJ; Rao DA; Alani AWG
    J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
    Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
    Molecules; 2018 May; 23(5):. PubMed ID: 29762537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity.
    Wattanapitayakul SK; Chularojmontri L; Herunsalee A; Charuchongkolwongse S; Niumsakul S; Bauer JA
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):80-7. PubMed ID: 15667600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity.
    Qureshi R; Yildirim O; Gasser A; Basmadjian C; Zhao Q; Wilmet JP; Désaubry L; Nebigil CG
    PLoS One; 2015; 10(11):e0141826. PubMed ID: 26536361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinochrome D Attenuates Doxorubicin-Induced Cardiomyocyte Death via Improving Glutathione Metabolism and Attenuating Oxidative Stress.
    Yoon CS; Kim HK; Mishchenko NP; Vasileva EA; Fedoreyev SA; Stonik VA; Han J
    Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
    Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
    Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells.
    Liu MH; Lin XL; Yuan C; He J; Tan TP; Wu SJ; Yu S; Chen L; Liu J; Tian W; Chen YD; Fu HY; Li J; Zhang Y
    Mol Med Rep; 2016 Jan; 13(1):367-72. PubMed ID: 26573464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-mitogenic FGF2 protects cardiomyocytes from acute doxorubicin-induced toxicity independently of the protein kinase CK2/heme oxygenase-1 pathway.
    Koleini N; Nickel BE; Edel AL; Fandrich RR; Ravandi A; Kardami E
    Cell Tissue Res; 2018 Dec; 374(3):607-617. PubMed ID: 30159756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.
    Berdichevski A; Meiry G; Milman F; Reiter I; Sedan O; Eliyahu S; Duffy HS; Youdim MB; Binah O
    J Pharmacol Exp Ther; 2010 Feb; 332(2):413-20. PubMed ID: 19915070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spironolactone Attenuates Doxorubicin-induced Cardiotoxicity in Rats.
    Liu G; Liu Y; Wang R; Hou T; Chen C; Zheng S; Dong Z
    Cardiovasc Ther; 2016 Aug; 34(4):216-24. PubMed ID: 27097055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolites of the cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicity.
    Hasinoff BB; Schroeder PE; Patel D
    Mol Pharmacol; 2003 Sep; 64(3):670-8. PubMed ID: 12920203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.
    Popelová O; Sterba M; Hasková P; Simůnek T; Hroch M; Guncová I; Nachtigal P; Adamcová M; Gersl V; Mazurová Y
    Br J Cancer; 2009 Sep; 101(5):792-802. PubMed ID: 19623174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice.
    Yao YF; Liu X; Li WJ; Shi ZW; Yan YX; Wang LF; Chen M; Xie MY
    Life Sci; 2017 Jul; 180():151-159. PubMed ID: 27956351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
    Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
    J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo.
    Zhang SH; Wang WQ; Wang JL
    Acta Pharmacol Sin; 2009 Nov; 30(11):1479-87. PubMed ID: 19890356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
    Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
    Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac protective effects of dexrazoxane on animal cardiotoxicity model induced by anthracycline combined with trastuzumab is associated with upregulation of calpain-2.
    Zhang S; Meng T; Liu J; Zhang X; Zhang J
    Medicine (Baltimore); 2015 Jan; 94(4):e445. PubMed ID: 25634181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.